1025070-12-5

Basic information

• Product Name: [(3β)-N-(2-hydroxy-1,1-dimethylethyl)-3-[4-(phenylmethoxy)carbonyl-3,3-dimethyl-1-oxobutoxy]lup-20(29)-en-28-yl]acetamide
• Synonyms: [(3β)-N-(2-hydroxy-1,1-dimethylethyl)-3-[4-(phenylmethoxy)carbonyl-3,3-dimethyl-1-oxobutoxy]lup-20(29)-en-28-yl]acetamide
• CAS NO: 1025070-12-5
• Molecular Weight: 788.164
• Mol File: 1025070-12-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [(3β)-N-(2-hydroxy-1,1-dimethylethyl)-3-[4-(phenylmethoxy)carbonyl-3,3-dimethyl-1-oxobutoxy]lup-20(29)-en-28-yl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: [(3β)-N-(2-hydroxy-1,1-dimethylethyl)-3-[4-(phenylmethoxy)carbonyl-3,3-dimethyl-1-oxobutoxy]lup-20(29)-en-28-yl]acetamide(1025070-12-5)
• EPA Substance Registry System: [(3β)-N-(2-hydroxy-1,1-dimethylethyl)-3-[4-(phenylmethoxy)carbonyl-3,3-dimethyl-1-oxobutoxy]lup-20(29)-en-28-yl]acetamide(1025070-12-5)

Safety Data

• Hazardous Substances Data: 1025070-12-5(Hazardous Substances Data)

Upstream product

• 59868-82-5 3-O-acetylbetulinic acid chloride 
• 90393-31-0 3,3-dimethylqlutaric acid monobenzyl ester 
• 10376-50-8 3-O-acetylbetulinic acid 
• 472-15-1 Betulinic acid 
• 13159-28-9 betulinic aldehyde 
• 473-98-3 betulin 
• 1025068-78-3 methyl [(3β)-3-[4-(phenylmethoxy)carbonyl-3,3-dimethyl-1-oxobutoxy]lup-20(29)-en-28-yl]acetate 
• 1025068-79-4 [(3β)-3-[4-(phenylmethoxy)carbonyl-3,3-dimethyl-1-oxobutoxy]lup-20(29)-en-28-yl]acetic acid 
• 1025068-55-6 (3β)-3-acetyloxy-N-methoxy-N-methyl-lup-20(29)-en-28-amide 
• 124-68-5 2-Amino-2-methyl-1-propanol 

Relevant articles and documents

EXTENDED TRITERPENE DERIVATIVES

The present invention concerns novel pharmaceutically active triterpene derivatives, pharmaceutical compositions containing the same, their use as medicaments, and the use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the compounds. Specifically, the compounds are derivatives of betulinic acid having substitutions at one or more of the C-3, C2-8 and C-19 positions as further described herein. The novel compounds are useful as antiretroviral agents. In particular, the novel compounds are useful for the treatment of Human Immunodeficiency Virus (HIV).